Evan David Seigerman
Stock Analyst at BMO Capital
(0.75)
# 2173
Out of 5,327 analysts
43
Total ratings
28.12%
Success rate
8.04%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NVO Novo Nordisk | Downgrades: Market Perform | 105 64 | 65.13 | -1.73% | 6 | Apr 17, 2025 | |
MRK Merck & Co | Maintains: Market Perform | 105 96 | 84.71 | 13.33% | 4 | Feb 5, 2025 | |
ABBV AbbVie | Maintains: Outperform | 208 215 | 193.51 | 11.11% | 7 | Feb 3, 2025 | |
REPL Replimune Group | Maintains: Outperform | 18 27 | 9.39 | 187.54% | 3 | Jan 22, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 1300 1190 | 568.91 | 109.17% | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | n/a | n/a | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 25.91 | 285.95% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 336 355 | 288.73 | 22.95% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 23.8 | 51.26% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | n/a | n/a | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 4.83 | -37.89% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 885.22 | -55.27% | 1 | Sep 6, 2022 |